Authors/Disclosures
|
Martha Morrell, MD, FAAN
(NeuroPace/Stanford University)
|
Dr. Morrell has received personal compensation for serving as an employee of NeuroPace. Dr. Morrell has stock in NeuroPace. The institution of Dr. Morrell has received research support from National Institutes of Health. |
|
|
No disclosure on file |
|
Tad D. Seifert, MD
|
Dr. Seifert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly Pharmaceuticals. Dr. Seifert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen Pharmaceuticals. Dr. Seifert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck Pharmaceuticals . Dr. Seifert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Supernus Pharmaceuticals . Dr. Seifert has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eli Lilly Pharmaceuticals . Dr. Seifert has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis Pharmaceuticals . |
|
|
No disclosure on file |
|
Kristen K. Steenerson, MD
|
Dr. Steenerson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Otolith. The institution of Dr. Steenerson has received research support from Wu Tsai Neurosciences Institute, Stanford University. |
|
Alan R. Hirsch, MD, FACP
(Illinois Center for Neurologial and Behavioral Medicine, Ltd.)
|
Dr. Hirsch has nothing to disclose. |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Jouko I. Isojarvi, MD, PhD
(Lundbeck)
|
No disclosure on file |